Plus   Neg

MGM Resorts Appoints Bill Hornbuckle As Acting CEO; Paul Salem As Chairman

MGM Resorts International (MGM) said it appointed its Chief Operating Officer and President Bill Hornbuckle as acting Chief Executive Officer and President, replacing outgoing Chairman and CEO Jim Murren.

Murren informed the company in early February of his plans to step down prior to the expiration of his contract, and in light of the public health crisis gripping the nation and the travel industry, has vacated the position as of today so as to provide continuity of leadership for the company.

Paul Salem has been appointed as Chairman of the company. He currently is a member of the MGM Resorts Board of Directors and Chair of the real estate committee of MGM Resorts.

According to reports, Nevada Governor Steve Sisolak has formed a statewide task force to help mitigate the spread of COVID-19. The task force will be led by Jim Murren, former CEO of MGM Resorts. Murren will begin the position immediately in an unpaid, voluntary position.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT